Q
QNCX//CIK 0001662774
Quince Therapeutics, Inc.
Market Data
$18.88+$0.82 (+4.54%)
QNCX · Last trade
Prev Close
$18.06
Range (29d)
$16.75 – $19.52
Recent Filings
- 8-K/A147.5 KBQuince Therapeutics, Inc.Jun 26, 4:31 PM ET·0001193125-26-285572
- 8-K158.0 KBQuince Therapeutics, Inc.Jun 26, 9:18 AM ET·0001193125-26-284089
- 8-K151.9 KBQuince Therapeutics, Inc.Jun 11, 5:06 PM ET·0001193125-26-267862
- 8-K137.8 KBQuince Therapeutics, Inc.May 21, 5:06 PM ET·0001193125-26-234858
- 8-K/A182.7 KBQuince Therapeutics, Inc.May 18, 4:20 PM ET·0001193125-26-228956
- 8-K6.1 MBQuince Therapeutics, Inc.May 18, 9:33 AM ET·0001193125-26-228133
- 10-Q11.9 MBQuince Therapeutics, Inc.May 11, 5:09 PM ET·0001193125-26-217098
- 8-K138.7 KBQuince Therapeutics, Inc.Apr 28, 4:30 PM ET·0001193125-26-187243
- 8-K140.0 KBQuince Therapeutics, Inc.Apr 22, 4:30 PM ET·0001193125-26-170572
- 10-K16.8 MBQuince Therapeutics, Inc.Apr 10, 4:35 PM ET·0001193125-26-151364
Insiders
10- Benatti LucaDirector
- Boeding Chad10% Owner
- Bray JuneDirector
- Detke Michael J.Chief Medical Officer
- Dominy Stephen S.Director, Chief Scientific Officer
- EPIQ Capital Group, LLCIA/Managing Member 10% owner
- Gafric KristenSVP, Legal & Administration
- Hannah BrendanCBO, COO & CCO
- Holsinger LeslieExecutive Vice President
- Janhofer GuenterChief Scientific Officer
Tickers
Addresses
business
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
mailing
611 GATEWAY BLVD., SUITE 273
SOUTH SAN FRANCISCO, CA, 94080
Former Names
- Cortexyme, Inc.2022-08-01